EXOZ
Income statement / Annual
Last year (2024), eXoZymes, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, eXoZymes, Inc.'s net income was -$5.86 M.
See eXoZymes, Inc.,s key income statements, including revenue, expenses, profit, and income.
Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
Cost of Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Gross Profit |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Gross Profit Ratio |
0
|
0
|
0
|
0
|
Research and Development Expenses |
$1.87 M
|
$527,480.00
|
$376,682.00
|
$454,454.00
|
General & Administrative Expenses |
$4.06 M
|
$1.34 M
|
$984,583.00
|
$838,391.00
|
Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Selling, General & Administrative Expenses |
$4.06 M
|
$1.34 M
|
$984,583.00
|
$838,391.00
|
Other Expenses |
$0.00
|
-$70,069.00
|
-$28,598.00
|
$0.00
|
Operating Expenses |
$5.93 M
|
$1.80 M
|
$1.33 M
|
$1.29 M
|
Cost And Expenses |
$5.93 M
|
$1.80 M
|
$1.33 M
|
$1.29 M
|
Interest Income |
$0.00
|
$100.00
|
$98.00
|
$0.00
|
Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
Depreciation & Amortization |
$267,382.00
|
$196,937.00
|
$147,751.00
|
$59,405.00
|
EBITDA |
-$5.66 M |
-$1.60 M |
-$1.18 M |
-$1.23 M |
EBITDA Ratio |
0
|
0
|
0
|
0
|
Operating Income Ratio |
0
|
0
|
0
|
0
|
Total Other Income/Expenses Net |
$70,770.00
|
-$199,900.00
|
$98.00
|
$83,739.00
|
Income Before Tax |
-$5.86 M
|
-$2.00 M
|
-$1.33 M
|
-$1.21 M
|
Income Before Tax Ratio |
0
|
0
|
0
|
0
|
Income Tax Expense |
$0.00
|
$42,267.00
|
$63,559.00
|
$0.00
|
Net Income |
-$5.86 M
|
-$2.04 M
|
-$1.40 M
|
-$1.21 M
|
Net Income Ratio |
0
|
0
|
0
|
0
|
EPS |
0 |
-0.25 |
-0.17 |
-0.15 |
EPS Diluted |
0 |
-0.25 |
-0.17 |
-0.15 |
Weighted Average Shares Out |
$8.13 M
|
$8.13 M
|
$8.13 M
|
$8.13 M
|
Weighted Average Shares Out Diluted |
$8.13 M
|
$8.13 M
|
$8.13 M
|
$8.13 M
|
Link |
|
|
|
|